Willem Witlox - Dissemin

All papers authored by Willem Witlox

This paper was not found in any repository, but could be made available legally by the author.

2021 Willem J. A. Witlox

, Bram L. T. Ramaekers

, Benjamin Lacas, Cecile Le Pechoux, Alexander Sun

, Si-Yu Wang, Chen Hu

, Mary Redman

, Vincent van der Noort, Ning Li, Matthias Guckenberger, Harm van Tinteren, Harry J. M. Groen, Manuela A. Joore, Dirk K. M. De Ruysscher

Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials

Upload

2020 Haiyan Zeng

, Lizza E. L. Hendriks

, Wouter H. van Geffen, Willem J. A. Witlox

, Danielle B. P. Eekers, Dirk K. M. De Ruysscher

Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic review

Upload

W. J. A. Witlox

, B. L. T. Ramaekers

, M. A. Joore

, A.-M. C. Dingemans, J. Praag, J. Belderbos, C. Tissing-Tan, G. Herder, T. Haitjema, J. F. Ubbels, J. Lagerwaard, S. Y. El Sharouni, J. A. Stigt, E. F. Smit, H. van Tinteren

and 3 other authors

Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study

Upload

2019 Willem J. A. Witlox

, Antoinette D. I. van Asselt, Robert Wolff, Nigel Armstrong, Gill Worthy, Annette Chalker, Titas Buksnys, Lisa Stirk, Jos Kleijnen, Manuela A. Joore

, Sabine E. Grimm

Durvalumab for the Treatment of Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Upload

W. J. A. Witlox

, B. L. T. Ramaekers, H. J. M. Groen, A. M. Dingemans, J. Praag, J. Belderbos, V. van der Noort, H. van Tinteren

, M. A. Joore

, D. K. M. De Ruysscher

Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study

Upload

Sabine E. Grimm

, Debra Fayter, Bram L. T. Ramaekers, Svenja Petersohn, Rob Riemsma, Nigel Armstrong, Xavier Pouwels, Willem Witlox

, Caro Noake, Gillian Worthy, Jos Kleijnen, Manuela A. Joore

Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Upload

Willem J. A. Witlox

, Frits H. M. van Osch, Maree Brinkman, Sylvia Jochems, Maria E. Goossens, Elisabete Weiderpass, Emily White, Piet A. van den Brandt, Graham G. Giles, Roger L. Milne, Inge Huybrechts, Hans-Olov Adami, Bas Bueno-De-Mesquita, Anke Wesselius

, Maurice P. Zeegers

An inverse association between the Mediterranean diet and bladder cancer risk: a pooled analysis of 13 cohort studies

Upload

2018 Bram L. T. Ramaekers

, Rob Riemsma, Sabine Grimm, Debra Fayter, Sohan Deshpande, Nigel Armstrong, Willem Witlox

, Xavier Pouwels, Steven Duffy, Gill Worthy, Jos Kleijnen, Manuela A. Joore

Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Upload

This paper is made freely available by the publisher.

Willem J. A. Witlox

, Bram L. T. Ramaekers, Jaap D. Zindler, Daniëlle B. P. Eekers, Judith G. M. van Loon, Lizza E. L. Hendriks, Anne-Marie C. Dingemans, Dirk K. M. De Ruysscher

The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation

Download from doi.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Willem Witlox